Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer

Overview of attention for article published in Cancer & Metabolism, May 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

patent: 1 patent

Readers on

mendeley: 28 Mendeley

So far, Altmetric has seen 1 patent that references this research output.

DUAL INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 AND TDO) AND THEIR USE IN THERAPY

Application WO-2023166492-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.